Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:33 AM
Ignite Modification Date:
2025-12-25 @ 3:33 AM
NCT ID:
NCT02606305
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with advanced epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer
* Folate receptor α (FRα) positive tumor expression as defined in the protocol
* Willing to provide an archival tumor tissue block or slides or undergo tumor biopsy. New tumor biopsy (Cycle 2 Day 8) is required for Regimen D.
* Measurable disease
Exclusion Criteria:
* Primary platinum-refractory disease
* Diagnosis of clear cell, low grade ovarian cancer or mixed tumors
* Serious concurrent illness or clinically relevant active infection, including but not limited to known diagnosis of human immunodeficiency virus (HIV) and hepatitis B or C, as defined in the protocol
* Active autoimmune disease requiring systemic therapy in past 2 years (for Regimen D only)
* Women who are pregnant or breastfeeding
* Male participants
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02606305
Study Brief:
Protocol Section:
NCT02606305